Contact:
4008465777
01/01
Products
-
BiopharmaceuticalsWe are the first company in China that launched the human insulin products. For more than 20 years, we have been engaged in the research and development (R&D), production, and marketing of insulin products that surpass international quality standards. Our products include a series of human insulin and insulin analogs.
More
-
TCM And Chemical MedicinesCombining the best of traditional Chinese medicine and modern western pharmaceuticals, we are committed to developing effective, highly-reputed medicines for fatty liver and vascular neuropathic headache.
More
-
Medical DevicesOur world-class insulin delivery devices can give diabetic patients a better injection experience.
More
Tonghua Dongbao has been persistent in continuous product innovation. The constant optimization of the product mix for diabetes treatment has enabled us to keep strengthening our market competitiveness and lead the domestic industry.
About Us
Tonghua Dongbao developed China's first recombinant human insulin, with a trade name of Gansulin, in 1998. As the first of its kind in China, Gansulin helped China overcome years of dependence on imports of the medicine. This achievement won the second prize of the National Science and Technology Progress Award and was listed in the "Top 10 Scientific Breakthroughs 1998". Let’s get a glimpse into Tonghua Dongbao from the following figures.
1985
Year of founding
RMB 30.75bn
Realize operating income (2023)
387+
Number of R&D staff
26+
Categories of popular products
